Delivery Order SPE2DB24D1201-SPE2DB25FJDUL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 40 mg chew tablets (100 count) with a ceiling value of $2,039.64. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The order is scheduled for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This competitively awarded, firm fixed-price contract requires performance at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive role...
- The Defense Logistics Agency awarded a delivery order valued at $3,879.40 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100-count units) valued at $3,095.96. This competitively awarded, firm fixed-price contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,117.25 on July 22, 2025, for the supply of Quillichew ER 20 MG chew tablets (100-count units). This firm fixed-price, competitively awarded contract represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 2026....
- On July 25, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,130.06 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, is issued under a non-set-aside competitive procurement and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units) with a ceiling value of $3,172.60. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order with an ultimate completion date of August 26, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Quillichew ER 30 mg chew tablets (100 count) with a ceiling value of $2,031.26 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chew tablets (100 count) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDULDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,752.85 and an ultimate completion date of August 7, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its competitive federal contracting activity, AmerisourceBergen demonstrates robust capability to fulfill diverse medical supply requirements, ranging from small-value transactions to substantial orders exceeding $45,000. The company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key provider within the federal pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/6/25 |